GoingToMeet

The Sixth Annual Multidisciplinary Symposium on Head and Neck Cancer addresses advances in our understanding of the biology and treatment of head and neck cancer. Timely topics such as biomarkers, including HPV and other emerging prognostic/predictive markers, and the multimodality management of locally advanced disease, including surgical approaches, radiation therapy, and chemoradiation therapy, will be addressed. Current data on targeted agents such as inhibitors of EGFR and other novel agents will be presented.

Finally, chemoprevention in head and neck cancer will be discussed. In addition to didactic lectures, case-based panel discussions, question-and-answer sessions, the symposium will feature a lunchtime multidisciplinary case management session illustrating the interaction and cooperation between the different branches of oncology.